May contain inaccuracies · Check primary sources · Not medical advice · Not for human or animal use

Peptide

GHK-Cu

Also known as

Copper peptide · GHK copper · glycyl-L-histidyl-L-lysine copper · GHK-Cu copper tripeptide · copper tripeptide-1 (cosmetic INCI contexts) · Gly-His-Lys-Cu · copper tripeptide-1

Community talk. May contain inaccuracies. Not medical advice. Not a protocol. Not for human or animal use.

What it is

Copper-binding peptideA three-amino-acid peptide bound to copper, also called copper tripeptide-1.
Why people discuss itPeople hope for smoother-looking skin, less noticeable fine lines, existing scars becoming less noticeable and fuller-looking hair.
Forms discussedSkin and scalp products, and injections beneath the skin (SubQ). Results from one form do not show what to expect from another.
Notes

A small peptide bound to copper. GHK links three amino acids: glycine, histidine and lysine. GHK-Cu is its copper complex; copper tripeptide-1 is a cosmetic name. Tissue-remodeling research and user reports explain its skin-repair reputation without establishing that injections reverse aging. Badenhorst et al. (2016): Effects of GHK-Cu on MMP and TIMP Expression, Collagen and Elastin Production, and Facial Wrinkle Parameters (Official context · Accessed 2026-09-30)

Smoother texture, fewer visible lines and a healthier-looking glow. An 11-week injection log described marked skin improvement and early sting that later eased. Other skincare and uncontrolled photographs limit the conclusion. GHK-Cu 11 weeks progress — jbizzle81 (Personal report · Accessed 2026-09-30)

Fuller-looking hair and better-looking scars. Hair reports describe thickness, shine or less shedding. Some users also use minoxidil, finasteride, needling or other peptides, making GHK-Cu's contribution difficult to separate. Reports of better-looking skin or less noticeable scars during injury stacks do not establish tendon repair. GHK-Cu 11 weeks progress — jbizzle81 (Personal report · Accessed 2026-09-30)

Serums, scalp products and injections are different exposures. Topical accounts concern complexion or scalp appearance. SubQ means injection beneath the skin. GLOW adds BPC-157 and TB-500 to GHK-Cu; KLOW also adds KPV. A blend result cannot identify one ingredient's effect. GHK-Cu Topical vs Injectable (My Personal Experience) (Community discussion · Accessed 2026-09-30)

Source context — Badenhorst et al. (2016): Effects of GHK-Cu on MMP and TIMP Expression, Collagen and Elastin Production, and Facial Wrinkle Parameters: Small commercial-formulation trial with industry funding and laboratory arm. Not standalone injection efficacy, long-term safety, human intact-complex kinetics or community serum optimization. 71-person study mentioned in introduction is prior work, not this trial.

Source context — GHK-Cu 11 weeks progress — jbizzle81: Linked pictures were not visually inspected. Account and products unverified. Author's expectation of hair changes around month four is not observed regrowth. Preparation/site instructions excluded.

Source context — GHK-Cu Topical vs Injectable (My Personal Experience): Self-reports with tretinoin, SNAP-8, tranexamic acid and other compounds; no head-to-head trial. PIP means post-injection pain. Vendor suggestions and mixing/needle instructions not reused.

What people notice

Skin appearanceSome people report firmer, smoother or more even-looking skin.
Hair appearanceSome people report thicker-looking hair or less shedding. Some also used minoxidil, finasteride or other treatments, so their reports cannot isolate GHK-Cu's contribution.
Less noticeable scarsSome people report that existing scars become less noticeable.
Immediate sensationSome injection accounts describe sting or soreness; others report none. Sting does not demonstrate benefit.
Worse-looking skinDryness, breakouts, crepey appearance or deeper-looking lines are also reported.
Notes

Skin firmness/texture: Firmer, smoother skin and fine-line talk over multi-week consistent use; photo reassess common at 8–12 weeks. [community]

Tone / glow: “Healthier glow,” even tone, or post-procedure recovery look before big structural change. [anecdote]

No visible improvement is also reported. One poster saw no skin/hair change after six weeks of 2 mg injections five days weekly. A reply reported no dramatic improvement after five months at 1–3 mg. Replies suggesting more time or zinc did not establish a cause. No results from GHK-Cu yet? (Community discussion · Accessed 2026-09-30)

Fuller-looking hair and better-looking scars. Hair reports describe thickness, shine or less shedding. Some users also use minoxidil, finasteride, needling or other peptides, making GHK-Cu's contribution difficult to separate. Reports of better-looking skin or less noticeable scars during injury stacks do not establish tendon repair. GHK-Cu 11 weeks progress — jbizzle81 (Personal report · Accessed 2026-09-30)

Soft-tissue adjacency: Injury stacks that add GHK-Cu often credit skin/scar quality more than tendon “feel.” [anecdote]

Injection sting can appear immediately; visible changes usually take longer. A GLOW user described first-week wasp-like pain, including much of the first day and night. Others reported no sting. This is local discomfort, not a marker of remodeling. I want to try GHK-CU but I'm hesitant (Community discussion · Accessed 2026-09-30)

Site reactions range from none to substantial pain or skin damage. Reports include redness, warmth, swelling, bruising, itch, ache and blue/purple marks. FDA flags possible immune reactions from aggregation/peptide impurities and limited human injection-safety data. Color, a purity claim or absence of sting cannot establish safety. A MESO-Rx poster reported skin injury with slow closure after 5 mg/day for ten days; the cause was unverified. I want to try GHK-CU but I'm hesitant (Community discussion · Accessed 2026-09-30) · FDA: Certain bulk drug substances that may present significant safety risks (Official context · Accessed 2026-09-30) · Looking to begin GHK-cu (Community discussion · Accessed 2026-09-30)

“Copper uglies” is a description, not proof of beneficial repair. The term covers dryness, breakouts, crepey appearance or deeper lines. One post describes worsening after two months at 2 mg/day; a reply describes later improvement. Older notes place onset around weeks 2–5 and easing around 4–6. None guarantees recovery or proves the proposed collagen-breakdown explanation. Copper Ugglies! About 2 months in with taking GHK 2mg daily (Community discussion · Accessed 2026-09-30) · GHK-Cu experience — r/Biohacking (Community discussion · Accessed 2026-09-30)

Source context — No results from GHK-Cu yet?: Self-reported nonresponse and delayed onset; no verified products or endpoints. Replies suggesting more time, zinc or product problems cannot explain the OP's outcome.

Source context — GHK-Cu 11 weeks progress — jbizzle81: Linked pictures were not visually inspected. Account and products unverified. Author's expectation of hair changes around month four is not observed regrowth. Preparation/site instructions excluded.

Source context — I want to try GHK-CU but I'm hesitant: Blend account does not establish a solo GHK-Cu reaction or mechanism. Purity and histamine claims unverified. Preparation, needle depth, injection site, massage and zinc dosing instructions excluded.

Source context — FDA: Certain bulk drug substances that may present significant safety risks: Route-specific risk context; not an incidence estimate, diagnosis of a reported reaction, efficacy assessment or proof that cosmetic use validates injection.

Source context — Looking to begin GHK-cu: Confounded self-reports and speculation about cause/product quality. Short-half-life statement supplies no assay, species or measured number. Product preparation and sourcing excluded. Used sparingly; no safety assurance accepted.

Source context — Copper Ugglies! About 2 months in with taking GHK 2mg daily: OP title does not independently confirm administration route or whether the three weeks refer specifically to time off; prose does not infer stopping. Reply's cause explanations and advice to persist are not validated.

Source context — GHK-Cu experience — r/Biohacking: Unverified self-reports. KLOW estimate is the poster's arithmetic, not authenticated component exposure. Ok-Figures does not specify frequency. No mechanism or lasting-damage diagnosis established.

Doses people talk about

Solo SubQ chartsAbout 0.5–2 mg/day in community charts; higher amounts also circulate. These are reported totals, not safe limits.
One SubQ accountOne user reports skin improvement by week four at 0.8 mg, worsening at 1 mg and improvement after stopping. How often they used it was not stated.
A no-result account2 mg, five days per week for six weeks, with no visible skin or hair improvement. This is a separate person from the 0.8 mg/1 mg account.
Topical concentration0.1–2% in older consumer notes. One commenter reports breakouts at 3% and better tolerance at 0.5%; label percentages can describe different things.
Topical frequencyDaily, twice daily and a few times weekly all appear; formulations differ.
Blend amountsGLOW and KLOW milligrams include other peptides. Total blend milligrams are not GHK-Cu milligrams; component ratios and labels vary.
Notes

Solo SubQ charts: about 0.5–2 mg total per day. Preserved community/clinic charts emphasize 1–2 mg/day, with 0.5–1 mg lower-amount talk, 2–3 mg intensive logs and occasional 4 mg/day claims. Other patterns are 1–2 mg two or three times weekly or morning/evening splits. These are reported totals, not safe ceilings. One freshly opened commenter reports 3 mg twice daily (6 mg/day), an outlying account rather than a ceiling. Copper and zinc balance while taking GHK-Cu — my results (Community discussion · Accessed 2026-09-30)

Individual reports: 800 mcg, 1 mg and higher weekday amounts. One user improved by week four at 800 mcg (0.8 mg), worsened at 1 mg and improved after stopping; frequency was unstated. Another logged 1.5, then 2, then 2.5 mg on administration days, five days on/two off. This is not an escalation recommendation. GHK-Cu experience — r/Biohacking (Community discussion · Accessed 2026-09-30) · GHK-Cu 11 weeks progress — jbizzle81 (Personal report · Accessed 2026-09-30)

Useful skin improvement can coexist with a reason to stop. The 800-mcg user improved, worsened at 1 mg and improved after stopping. The questioner clarified KLOW use, estimating 2.5 mg GHK-Cu five times weekly. Solo and blend accounts cannot establish the same cause. GHK-Cu experience — r/Biohacking (Community discussion · Accessed 2026-09-30)

No visible improvement is also reported. One poster saw no skin/hair change after six weeks of 2 mg injections five days weekly. A reply reported no dramatic improvement after five months at 1–3 mg. Replies suggesting more time or zinc did not establish a cause. No results from GHK-Cu yet? (Community discussion · Accessed 2026-09-30)

Topical reports: 0.1–2% in older consumer notes; actual accounts disagree. A commenter reported breakouts at 3% and better tolerance at 0.5%. Another preferred daily SubQ to a 2% topical. LongeCity questions seller claims for 2%; laboratory concentrations cannot establish an ideal finished serum. GHK-CU Topical — concentration and tolerance discussion (Personal report · Accessed 2026-09-30) · GHK-Cu Topical vs Injectable (My Personal Experience) (Community discussion · Accessed 2026-09-30) · GHK-CU Topical dosage/concentration (Community opinion · Accessed 2026-09-30)

More concentrated is not a settled definition of better. Posts disagree over 1%, 3% and higher hair percentages. A reported breakout at 3% contrasts with claims it is optimal. Stock-solution or total-peptide percentages may differ from actual GHK-Cu concentration; no optimal percentage is established. GHK-CU Topical — concentration and tolerance discussion (Personal report · Accessed 2026-09-30) · GHK-cu topical serum percentage (Community opinion · Accessed 2026-09-30)

Topical frequency: once or twice daily, or intermittent use. Preserved accounts include every-other-night or two or three times weekly use. A PurseForum serum user applied it a couple times weekly and was unsure it helped. Vehicles and percentages of total peptide mixtures differ. Let's talk GHK-Cu (Community discussion · Accessed 2026-09-30)

GLOW 5:1:1 and KLOW 5:1:1:1 are component ratios. Preserved GLOW 50/10/10 mg GHK-Cu/BPC-157/TB-500 means about 2.33 mg total blend contains 1.67/0.33/0.33 mg respectively. KLOW adds 10 mg KPV for 80 mg total. Labels vary; blend milligrams differ from GHK-Cu milligrams.

Source context — Copper and zinc balance while taking GHK-Cu — my results: OP body and old author's lab values unavailable today. This ledger entry supports visible replies only. Old GLOW/lab account retained separately through frozen profile locator; replies are not human PK or copper-safety evidence.

Source context — GHK-Cu experience — r/Biohacking: Unverified self-reports. KLOW estimate is the poster's arithmetic, not authenticated component exposure. Ok-Figures does not specify frequency. No mechanism or lasting-damage diagnosis established.

Source context — GHK-Cu 11 weeks progress — jbizzle81: Linked pictures were not visually inspected. Account and products unverified. Author's expectation of hair changes around month four is not observed regrowth. Preparation/site instructions excluded.

Source context — No results from GHK-Cu yet?: Self-reported nonresponse and delayed onset; no verified products or endpoints. Replies suggesting more time, zinc or product problems cannot explain the OP's outcome.

Source context — GHK-CU Topical — concentration and tolerance discussion: Homemade formulation claims and concentration unverified. Claimed 3% saturation limit not accepted as a biological fact. Search dated July 8 versus relative displayed timestamps disagree; no exact publication date asserted.

Source context — GHK-Cu Topical vs Injectable (My Personal Experience): Self-reports with tretinoin, SNAP-8, tranexamic acid and other compounds; no head-to-head trial. PIP means post-injection pain. Vendor suggestions and mixing/needle instructions not reused.

Source context — GHK-CU Topical dosage/concentration: A question and laboratory-to-serum comparison, not a first-person outcome or validated topical amount. Linked studies not used as topical-dose evidence. DIY arithmetic not reproduced.

Source context — GHK-cu topical serum percentage: Unverified opinions and unsupported optimal-percentage assertions. Specific commercial formula composition is not verified by these commenters; prose treats it as a label-interpretation dispute. DIY recipes not reproduced.

Source context — Let's talk GHK-Cu: No verified chemistry, objective outcome or specified serum concentration. Forum carries affiliate disclosure. Linked before/after pictures not visually inspected. No purchase or soreness-reduction recipe reproduced.

Half-life, onset & duration

Visible skin changesSome logs describe changes around 4–6 weeks; others describe changes after several months. Photos are often compared at 8–12 weeks.
Hair changes12–16 weeks or longer is discussed as an expectation, not a guaranteed regrowth window.
Half-lifeNo reliable human value is identified here. Online estimates conflict; see Notes.
Duration after stoppingUncertain. There is no dependable single-use benefit window or lasting-after-stopping interval; local sting can outlast the injection.
Notes

Skin: around four to six weeks in some logs; months or no change in others. The 800-mcg account improved by week four; a mixed topical/injection account noticed changes around week six. Other replies describe month-four onset or none after five months. Older accounts include softness at 1–2 weeks and photos at 8–12 weeks. GHK-Cu experience — r/Biohacking (Community discussion · Accessed 2026-09-30) · GHK-Cu Topical vs Injectable (My Personal Experience) (Community discussion · Accessed 2026-09-30) · No results from GHK-Cu yet? (Community discussion · Accessed 2026-09-30)

Hair: 12–16 weeks or longer is discussed. The 11-week poster felt fuller, shinier hair but expected more changes around month four. Scalp discussions extend to 3–6 or 6–12 months. Expectations are not guaranteed regrowth. GHK-Cu 11 weeks progress — jbizzle81 (Personal report · Accessed 2026-09-30)

About 30 minutes, 105 minutes and 2–4 hours all circulate. These conflicting GHK-related figures persist in the community record. Their study, measured substance, species and route remain unresolved. They cannot establish a measured human GHK-Cu value; this review found no suitable human clearance study.

No dependable benefit duration for a single application or injection. Logs concern repeated use. One commenter felt smoothness faded during a month off; an adverse poster described three weeks without improvement. Benefit after stopping remains uncertain. Copper and zinc balance while taking GHK-Cu — my results (Community discussion · Accessed 2026-09-30) · Copper Ugglies! About 2 months in with taking GHK 2mg daily (Community discussion · Accessed 2026-09-30)

Local discomfort can outlast the injection. The GLOW account's first 1–2 days included day-and-night stinging, later less frequent. Symptom duration differs from half-life and course length. I want to try GHK-CU but I'm hesitant (Community discussion · Accessed 2026-09-30)

Source context — GHK-Cu experience — r/Biohacking: Unverified self-reports. KLOW estimate is the poster's arithmetic, not authenticated component exposure. Ok-Figures does not specify frequency. No mechanism or lasting-damage diagnosis established.

Source context — GHK-Cu Topical vs Injectable (My Personal Experience): Self-reports with tretinoin, SNAP-8, tranexamic acid and other compounds; no head-to-head trial. PIP means post-injection pain. Vendor suggestions and mixing/needle instructions not reused.

Source context — No results from GHK-Cu yet?: Self-reported nonresponse and delayed onset; no verified products or endpoints. Replies suggesting more time, zinc or product problems cannot explain the OP's outcome.

Source context — GHK-Cu 11 weeks progress — jbizzle81: Linked pictures were not visually inspected. Account and products unverified. Author's expectation of hair changes around month four is not observed regrowth. Preparation/site instructions excluded.

Source context — Copper and zinc balance while taking GHK-Cu — my results: OP body and old author's lab values unavailable today. This ledger entry supports visible replies only. Old GLOW/lab account retained separately through frozen profile locator; replies are not human PK or copper-safety evidence.

Source context — Copper Ugglies! About 2 months in with taking GHK 2mg daily: OP title does not independently confirm administration route or whether the three weeks refer specifically to time off; prose does not infer stopping. Reply's cause explanations and advice to persist are not validated.

Source context — I want to try GHK-CU but I'm hesitant: Blend account does not establish a solo GHK-Cu reaction or mechanism. Purity and histamine claims unverified. Preparation, needle depth, injection site, massage and zinc dosing instructions excluded.

Cycles people discuss

Solo injection blocks4–8 weeks on and 2–4 weeks off is one chart pattern. Alternatives include 30 days on/14–30 off or eight weeks on/eight off.
Weekday patternFive days on/two off appears in an 11-week log; it does not establish an optimal calendar.
Topical useOngoing skincare, intermittent use and pauses for irritation all appear.
Reasons for breaksCost, needles, irritation and copper concerns are cited. No proven tolerance-reset schedule is established.
Notes

Solo injection charts: 30 days on/14–30 days off, or 4–8-week blocks. Preserved alternatives are 4–8 weeks on/2–4 weeks off or eight weeks on/eight weeks off. Weekday use appears within 30–60 days. Cost, needles and copper concerns are reasons given; no proven tolerance-reset rule settles it.

Opening body lines 20–36: skin/hair impressions, three weeks at 1.5 mg, three at 2 mg, week seven onward at 2.5 mg, each five days on/two off; early sting and skincare context. GHK-Cu 11 weeks progress — jbizzle81 (Personal report · Accessed 2026-09-30)

Smoother texture, fewer visible lines and a healthier-looking glow. An 11-week injection log described marked skin improvement and early sting that later eased. Other skincare and uncontrolled photographs limit the conclusion. GHK-Cu 11 weeks progress — jbizzle81 (Personal report · Accessed 2026-09-30)

Continuous topical use and stopping for irritation coexist. Some keep skincare ongoing or pause for irritation. Others reject breaks or cycle injections. The inspected eight-week mixed-route account and 11-week weekday log describe courses without establishing an optimal calendar. GHK-Cu Topical vs Injectable (My Personal Experience) (Community discussion · Accessed 2026-09-30) · GHK-Cu 11 weeks progress — jbizzle81 (Personal report · Accessed 2026-09-30) · Copper Ugglies! About 2 months in with taking GHK 2mg daily (Community discussion · Accessed 2026-09-30)

Why cycle injectables at all: Cost, needle burden, copper-load caution, and thin chronic human SC data — not a proven “tolerance reset” law. [community]

Source context — GHK-Cu 11 weeks progress — jbizzle81: Linked pictures were not visually inspected. Account and products unverified. Author's expectation of hair changes around month four is not observed regrowth. Preparation/site instructions excluded.

Source context — GHK-Cu Topical vs Injectable (My Personal Experience): Self-reports with tretinoin, SNAP-8, tranexamic acid and other compounds; no head-to-head trial. PIP means post-injection pain. Vendor suggestions and mixing/needle instructions not reused.

Source context — Copper Ugglies! About 2 months in with taking GHK 2mg daily: OP title does not independently confirm administration route or whether the three weeks refer specifically to time off; prose does not infer stopping. Reply's cause explanations and advice to persist are not validated.

Stacks

GLOW and KLOWGLOW combines GHK-Cu, BPC-157 and TB-500; KLOW adds KPV. Premixes fix component ratios, and their outcomes cannot isolate one ingredient.
Skin and hair routinesMoisturizer, sunscreen, retinoids, minoxidil, finasteride and needling occur alongside it. Those routines can contribute to appearance changes too.
Zinc discussionSome add zinc; others dispute a universal need. No standardized companion amount is established.
Notes

Serums, scalp products and injections are different exposures. Topical accounts concern complexion or scalp appearance. SubQ means injection beneath the skin. GLOW adds BPC-157 and TB-500 to GHK-Cu; KLOW also adds KPV. A blend result cannot identify one ingredient's effect. GHK-Cu Topical vs Injectable (My Personal Experience) (Community discussion · Accessed 2026-09-30)

Premixes fix the component ratios and make individual effects harder to identify. Separate-vial talk includes BPC-157 250–500 mcg/day and TB-500 multi-milligram once or twice weekly schedules. Premixes lock them together; extra standalone GHK-Cu can confuse totals. Storage and color-change discussions do not authenticate contents.

Topical skin routine: GHK-Cu serum + moisturizer + SPF; rotate or time-separate strong AHA/BHA, high-strength L-ascorbic acid, and retinoids to reduce sting and inactivation fights. [community]

Hair stack confounds: Minoxidil, microneedling, finasteride/dutasteride, rosemary, other hair peptides (including AHK-Cu) — nearly impossible to isolate GHK-Cu credit. [community]

Skincare routines and photo conditions affect the comparison. Topical accounts describe cleansing/showering, serum then moisturizer after 1–5 minutes, and sunscreen; scalp accounts describe after-shampoo application and separate minoxidil timing. Other skincare and sleep can affect appearance, while different photo conditions make changes harder to judge.

Copper/zinc explanations remain contested. Some add zinc; others dispute a universal need. Copper, zinc, ceruloplasmin and liver tests appear in discussion, confounded by changing stacks and missing baselines. Headache/malaise are nonspecific reports. Pregnancy, lactation and cancer-history precautions reflect uncertainty around systemic research use. Copper and zinc balance while taking GHK-Cu — my results (Community discussion · Accessed 2026-09-30)

Zinc balance talk: Long/high injectable copper-peptide runs often pair with zinc supplementation discussion (copper–zinc antagonism lore) — not a standardized trial protocol. [community]

Source context — GHK-Cu Topical vs Injectable (My Personal Experience): Self-reports with tretinoin, SNAP-8, tranexamic acid and other compounds; no head-to-head trial. PIP means post-injection pain. Vendor suggestions and mixing/needle instructions not reused.

Source context — Copper and zinc balance while taking GHK-Cu — my results: OP body and old author's lab values unavailable today. This ledger entry supports visible replies only. Old GLOW/lab account retained separately through frozen profile locator; replies are not human PK or copper-safety evidence.

Watch for

Skin irritationDryness, breakouts and worse-looking texture are reported. The term copper uglies does not prove beneficial repair or guarantee that worsening will resolve.
Injection reactionsReports include sting, redness, swelling, bruising and pain; some describe substantial reactions or skin injury.
Injection safetyThe saved FDA record flags possible immune reactions from aggregation or peptide impurities, with limited human injection-safety data. Color or absence of sting cannot establish safety.
Layering and needlingAcids, retinoids and freshly needled skin can complicate irritation. Ordinary serum use does not establish safety on broken skin.
Copper balance and medical contextHeadache, malaise and copper–zinc concerns appear; symptoms alone cannot diagnose an imbalance. Systemic-use precautions in the record include pregnancy, lactation and cancer history.
Notes

“Copper uglies” is a description, not proof of beneficial repair. The term covers dryness, breakouts, crepey appearance or deeper lines. One post describes worsening after two months at 2 mg/day; a reply describes later improvement. Older notes place onset around weeks 2–5 and easing around 4–6. None guarantees recovery or proves the proposed collagen-breakdown explanation. Copper Ugglies! About 2 months in with taking GHK 2mg daily (Community discussion · Accessed 2026-09-30) · GHK-Cu experience — r/Biohacking (Community discussion · Accessed 2026-09-30)

Site reactions range from none to substantial pain or skin damage. Reports include redness, warmth, swelling, bruising, itch, ache and blue/purple marks. FDA flags possible immune reactions from aggregation/peptide impurities and limited human injection-safety data. Color, a purity claim or absence of sting cannot establish safety. A MESO-Rx poster reported skin injury with slow closure after 5 mg/day for ten days; the cause was unverified. I want to try GHK-CU but I'm hesitant (Community discussion · Accessed 2026-09-30) · FDA: Certain bulk drug substances that may present significant safety risks (Official context · Accessed 2026-09-30) · Looking to begin GHK-cu (Community discussion · Accessed 2026-09-30)

Layering and freshly needled skin complicate irritation. Community debates involve acids, retinoids, strong vitamin C and benzoyl peroxide. Their effects can overlap with GHK-Cu. Ordinary serum strength is not validated for open skin channels; “tenfold absorption” lore cannot determine a safe amount.

Copper/zinc explanations remain contested. Some add zinc; others dispute a universal need. Copper, zinc, ceruloplasmin and liver tests appear in discussion, confounded by changing stacks and missing baselines. Headache/malaise are nonspecific reports. Pregnancy, lactation and cancer-history precautions reflect uncertainty around systemic research use. Copper and zinc balance while taking GHK-Cu — my results (Community discussion · Accessed 2026-09-30)

Source context — Copper Ugglies! About 2 months in with taking GHK 2mg daily: OP title does not independently confirm administration route or whether the three weeks refer specifically to time off; prose does not infer stopping. Reply's cause explanations and advice to persist are not validated.

Source context — GHK-Cu experience — r/Biohacking: Unverified self-reports. KLOW estimate is the poster's arithmetic, not authenticated component exposure. Ok-Figures does not specify frequency. No mechanism or lasting-damage diagnosis established.

Source context — I want to try GHK-CU but I'm hesitant: Blend account does not establish a solo GHK-Cu reaction or mechanism. Purity and histamine claims unverified. Preparation, needle depth, injection site, massage and zinc dosing instructions excluded.

Source context — FDA: Certain bulk drug substances that may present significant safety risks: Route-specific risk context; not an incidence estimate, diagnosis of a reported reaction, efficacy assessment or proof that cosmetic use validates injection.

Source context — Looking to begin GHK-cu: Confounded self-reports and speculation about cause/product quality. Short-half-life statement supplies no assay, species or measured number. Product preparation and sourcing excluded. Used sparingly; no safety assurance accepted.

Source context — Copper and zinc balance while taking GHK-Cu — my results: OP body and old author's lab values unavailable today. This ledger entry supports visible replies only. Old GLOW/lab account retained separately through frozen profile locator; replies are not human PK or copper-safety evidence.

Full notes

GHK-Cu is a copper-binding peptide discussed for smoother skin, less visible fine lines and existing scars, and fuller-looking hair. Skincare users apply it topically; peptide users also report injections, alone or in GLOW/KLOW blends. Experiences range from visible improvement to no change or worse-looking skin, and those forms cannot be treated as equivalent.

What GHK-Cu is

  • A small peptide bound to copper. GHK links three amino acids: glycine, histidine and lysine. GHK-Cu is its copper complex; copper tripeptide-1 is a cosmetic name. Tissue-remodeling research and user reports explain its skin-repair reputation without establishing that injections reverse aging. Official context Community
  • Serums, scalp products and injections are different exposures. Topical accounts concern complexion or scalp appearance. SubQ means injection beneath the skin. GLOW adds BPC-157 and TB-500 to GHK-Cu; KLOW also adds KPV. A blend result cannot identify one ingredient's effect. Reddit r/BiohackingU Community

Benefits people seek and report

  • Smoother texture, fewer visible lines and a healthier-looking glow. An 11-week injection log described marked skin improvement and early sting that later eased. Other skincare and uncontrolled photographs limit the conclusion. Personal report
  • Fuller-looking hair and better-looking scars. Hair reports describe thickness, shine or less shedding. Some users also use minoxidil, finasteride, needling or other peptides, making GHK-Cu's contribution difficult to separate. Reports of better-looking skin or less noticeable scars during injury stacks do not establish tendon repair. Personal report Community Community
  • No visible improvement is also reported. One poster saw no skin/hair change after six weeks of 2 mg injections five days weekly. A reply reported no dramatic improvement after five months at 1–3 mg. Replies suggesting more time or zinc did not establish a cause. Reddit r/BiohackingU

Doses people discuss

Amounts below describe reports and circulated charts, not instructions. 1,000 mcg equals 1 mg.

  • Solo SubQ charts: about 0.5–2 mg total per day. Preserved community/clinic charts emphasize 1–2 mg/day, with 0.5–1 mg lower-amount talk, 2–3 mg intensive logs and occasional 4 mg/day claims. Other patterns are 1–2 mg two or three times weekly or morning/evening splits. These are reported totals, not safe ceilings. One freshly opened commenter reports 3 mg twice daily (6 mg/day), an outlying account rather than a ceiling. Community Reddit r/Biohacking
  • Individual reports: 800 mcg, 1 mg and higher weekday amounts. One user improved by week four at 800 mcg (0.8 mg), worsened at 1 mg and improved after stopping; frequency was unstated. Another logged 1.5, then 2, then 2.5 mg on administration days, five days on/two off. This is not an escalation recommendation. Reddit r/Biohacking Personal report
  • Topical reports: 0.1–2% in older consumer notes; actual accounts disagree. A commenter reported breakouts at 3% and better tolerance at 0.5%. Another preferred daily SubQ to a 2% topical. LongeCity questions seller claims for 2%; laboratory concentrations cannot establish an ideal finished serum. Community Personal report Reddit r/BiohackingU LongeCity
  • Topical frequency: once or twice daily, or intermittent use. Preserved accounts include every-other-night or two or three times weekly use. A PurseForum serum user applied it a couple times weekly and was unsure it helped. Vehicles and percentages of total peptide mixtures differ. Community PurseForum
  • GLOW 5:1:1 and KLOW 5:1:1:1 are component ratios. Preserved GLOW 50/10/10 mg GHK-Cu/BPC-157/TB-500 means about 2.33 mg total blend contains 1.67/0.33/0.33 mg respectively. KLOW adds 10 mg KPV for 80 mg total. Labels vary; blend milligrams differ from GHK-Cu milligrams. Community

Half-life

  • About 30 minutes, 105 minutes and 2–4 hours all circulate. These conflicting GHK-related figures persist in the community record. Their study, measured substance, species and route remain unresolved. They cannot establish a measured human GHK-Cu value; this review found no suitable human clearance study. Community
  • A short-half-life argument does not settle frequency. MESO-Rx uses presumed short clearance to argue for repeated injections; others use weekdays only. Those preferences do not measure intact peptide–copper clearance, and weeks of skin change cannot validate a blood half-life. MESO-Rx Community

Onset: when people notice a change

  • Injection sting can appear immediately; visible changes usually take longer. A GLOW user described first-week wasp-like pain, including much of the first day and night. Others reported no sting. This is local discomfort, not a marker of remodeling. Reddit r/Peptidesource
  • Skin: around four to six weeks in some logs; months or no change in others. The 800-mcg account improved by week four; a mixed topical/injection account noticed changes around week six. Other replies describe month-four onset or none after five months. Older accounts include softness at 1–2 weeks and photos at 8–12 weeks. Reddit r/Biohacking Reddit r/BiohackingU Reddit r/BiohackingU Community
  • Hair: 12–16 weeks or longer is discussed. The 11-week poster felt fuller, shinier hair but expected more changes around month four. Scalp discussions extend to 3–6 or 6–12 months. Expectations are not guaranteed regrowth. Personal report Community

Duration: how long changes last

  • No dependable benefit duration for a single application or injection. Logs concern repeated use. One commenter felt smoothness faded during a month off; an adverse poster described three weeks without improvement. Benefit after stopping remains uncertain. Reddit r/Biohacking Reddit r/PeptideForum
  • Local discomfort can outlast the injection. The GLOW account's first 1–2 days included day-and-night stinging, later less frequent. Symptom duration differs from half-life and course length. Reddit r/Peptidesource

Cycles and breaks

  • Solo injection charts: 30 days on/14–30 days off, or 4–8-week blocks. Preserved alternatives are 4–8 weeks on/2–4 weeks off or eight weeks on/eight weeks off. Weekday use appears within 30–60 days. Cost, needles and copper concerns are reasons given; no proven tolerance-reset rule settles it. Community
  • GLOW: four weeks on/2–4 weeks off; KLOW: 6–12-week blocks. GLOW accounts also describe 6–8 or 8–12 weeks; KLOW breaks are multi-week. Short 10–14-day injury add-ons are thinner stack-guide claims. Premixes prevent independent component schedules. Community Community
  • Continuous topical use and stopping for irritation coexist. Some keep skincare ongoing or pause for irritation. Others reject breaks or cycle injections. The inspected eight-week mixed-route account and 11-week weekday log describe courses without establishing an optimal calendar. Community Reddit r/BiohackingU Personal report Reddit r/PeptideForum

Good to know

  • “Copper uglies” is a description, not proof of beneficial repair. The term covers dryness, breakouts, crepey appearance or deeper lines. One post describes worsening after two months at 2 mg/day; a reply describes later improvement. Older notes place onset around weeks 2–5 and easing around 4–6. None guarantees recovery or proves the proposed collagen-breakdown explanation. Reddit r/PeptideForum Reddit r/Biohacking
  • Site reactions range from none to substantial pain or skin damage. Reports include redness, warmth, swelling, bruising, itch, ache and blue/purple marks. FDA flags possible immune reactions from aggregation/peptide impurities and limited human injection-safety data. Color, a purity claim or absence of sting cannot establish safety. A MESO-Rx poster reported skin injury with slow closure after 5 mg/day for ten days; the cause was unverified. Community Reddit r/Peptidesource Official context MESO-Rx
  • Layering and freshly needled skin complicate irritation. Community debates involve acids, retinoids, strong vitamin C and benzoyl peroxide. Their effects can overlap with GHK-Cu. Ordinary serum strength is not validated for open skin channels; “tenfold absorption” lore cannot determine a safe amount. Community Community
  • Copper/zinc explanations remain contested. Some add zinc; others dispute a universal need. Copper, zinc, ceruloplasmin and liver tests appear in discussion, confounded by changing stacks and missing baselines. Headache/malaise are nonspecific reports. Pregnancy, lactation and cancer-history precautions reflect uncertainty around systemic research use. Reddit r/Biohacking Community Community

From community discussion

  • The preferred route differs between people. One author preferred topical results because injection pain was annoying; a reply preferred 1 mg/day SubQ and saw little from 2% topical. Opposing impressions cannot rank the routes. Reddit r/BiohackingU
  • Useful skin improvement can coexist with a reason to stop. The 800-mcg user improved, worsened at 1 mg and improved after stopping. The questioner clarified KLOW use, estimating 2.5 mg GHK-Cu five times weekly. Solo and blend accounts cannot establish the same cause. Reddit r/Biohacking
  • Changing stacks make copper/zinc tests hard to interpret. One archived account reports 1.5 mg during GLOW use six days weekly, worsening after two weeks, a two-week pause, then separate GHK-Cu four nights weekly. Component/total ambiguity, zinc changes, Wolverine co-use and no pre-use labs prevent causal interpretation. Community
  • Skincare routines and photo conditions affect the comparison. Topical accounts describe cleansing/showering, serum then moisturizer after 1–5 minutes, and sunscreen; scalp accounts describe after-shampoo application and separate minoxidil timing. Other skincare and sleep can affect appearance, while different photo conditions make changes harder to judge. Community Community
  • More concentrated is not a settled definition of better. Posts disagree over 1%, 3% and higher hair percentages. A reported breakout at 3% contrasts with claims it is optimal. Stock-solution or total-peptide percentages may differ from actual GHK-Cu concentration; no optimal percentage is established. Personal report Reddit r/Peptidesource
  • Premixes fix the component ratios and make individual effects harder to identify. Separate-vial talk includes BPC-157 250–500 mcg/day and TB-500 multi-milligram once or twice weekly schedules. Premixes lock them together; extra standalone GHK-Cu can confuse totals. Storage and color-change discussions do not authenticate contents. Community Community Community

Supporting research and regulatory context

  • Topical formulation research does not validate injection charts. Badenhorst's 2016 split-face study involved 40 women aged 40–65, eight weeks and a carrier-enhanced serum. Results are formulation-specific; Snowberry helped fund it. The cited older 71-person trial is not this study. Official context
  • Non-injectable compounding review is distinct from drug approval. FDA's May 14, 2026 list returned non-injectable GHK-Cu to Category 1 and records withdrawal of the injectable nomination. It states intended consultation before February 2027 ends. Evaluation status is not approval. Official context

Open in the directory ↗All STUDresearch topics →